Pfizer Selects Prosonix Technology

Ultrasonic process technology company Prosonix (Oxford, U.K.) says its Prosonitron reactor and sonocrystallization process technology has been selected by Pfizer for the pharma group’s active pharmaceutical ingredients (API) manufacturing facilities in Ireland. The Prosonitron technology was selected after an extended period of collaboration and testing with Pfizer’s R&D team at Sandwich, U.K., Prosonix says. The Prosonitron technology will be used in the controlled crystallization and production of a number of Pfizer products, Prosonix says. The...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers